Carna Biosciences, Inc.
JPX: 4572.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Kohichiro Yoshino
- Employees
- 63
- Headquarters
- Kobe, Japan
- IPO year
- 2008
- Market cap
- ¥7.6B
- Website
- https://www.carnabio.com
Loading 4572…
Loading profile data…Frequently asked questions about 4572
What does Carna Biosciences, Inc. (4572.T) do?
Carna Biosciences, Inc., a clinical-stage biopharmaceutical company, discovers and develops drug therapies to treat unmet medical needs in Japan. Its products include kinase proteins, substrates, kinase protein assay kits, and stable cell lines, as well as biotinylated kinases to use in the study of kinase-molecule interactions. The company also...
Where does 4572.T trade?
Carna Biosciences, Inc. (4572.T) trades on the Tokyo Stock Exchange.
What sector is 4572.T in?
Carna Biosciences, Inc. (4572.T) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Carna Biosciences, Inc.?
Kohichiro Yoshino is the chief executive officer of Carna Biosciences, Inc. (4572.T).
Where is Carna Biosciences, Inc. headquartered?
Carna Biosciences, Inc. is headquartered in Japan.
Does 4572.T pay a dividend?
Carna Biosciences, Inc. (4572.T) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 4572.T go public?
Carna Biosciences, Inc. (4572.T) completed its initial public offering in 2008.